BSD Medical Corporation
BSD Medical Files FDA 510k Submission to Market Phase II MicroThermX Ablation System
Published in Medical Letter on the CDC and FDA, April 11th, 2010
BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) announced that the Company has filed a 510(k) submission with the U.S. Food and Drug Administration (FDA) for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of the 510(k) Premarket Notification submission will authorize commercial distribution of the MTX-180 in the United States.
The MTX-180 employs precision-guided microwave energy to ablate (destroy or vaporize) soft tissue. The MTX-180 is a compact, mobile system that includes a state-of-the-art computer, a microwave generator, single-patient-use disposable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Radiological Society of North America
Chest X-rays can help predict which H1N1 patients are at greatest risk - Scripps Research Institute
Scripps research team finds structure of 'swine flu' virus - Society for Research in Child Development
Early child-parent attachment affects behavior, especially for boys - BioSante Pharmaceuticals, Inc.
BioSante Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug Designation - Human Genome Sciences, Inc.
Human Genome Sciences Announces Interim Results of Phase 2b Monthly-Dosing Trial of ZALBIN(TM) in Patients with Chronic Hepatitis C - Novavax, Inc.
NOVAVAX Announces Positive Clinical Results from First Stage of Pivotal Study of 2009 A/H1N1 VLP Pandemic Influenza Vaccine in Mexico - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
